What is a common caution with Metformin use for pediatric obesity?

Prepare for the MTM Pediatric Obesity Test with our comprehensive study aids. Use flashcards and multiple choice questions, each with detailed explanations and hints. Ensure you're ready for the exam!

Multiple Choice

What is a common caution with Metformin use for pediatric obesity?

Explanation:
Gastrointestinal intolerance is the common caution with metformin in pediatric obesity. Diarrhea, abdominal pain, nausea, and vomiting often appear, especially when starting treatment or increasing the dose, and can limit adherence. You can reduce these effects by starting at a low dose and titrating up slowly, taking the medication with meals, and using an extended-release formulation if available. In contrast, weight gain, hair loss, or increased appetite are not typical concerns with metformin; it is more likely to be weight-neutral or associated with modest weight loss in some patients. Also keep in mind rare but serious risks like lactic acidosis, so renal function should be monitored and hydration maintained.

Gastrointestinal intolerance is the common caution with metformin in pediatric obesity. Diarrhea, abdominal pain, nausea, and vomiting often appear, especially when starting treatment or increasing the dose, and can limit adherence. You can reduce these effects by starting at a low dose and titrating up slowly, taking the medication with meals, and using an extended-release formulation if available. In contrast, weight gain, hair loss, or increased appetite are not typical concerns with metformin; it is more likely to be weight-neutral or associated with modest weight loss in some patients. Also keep in mind rare but serious risks like lactic acidosis, so renal function should be monitored and hydration maintained.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy